Breaking News

Breaking news filtered in real-time to show only the most impactful headlines for US-listed public companies.

BLP Expands National Footprint with 1.56M SF Atlanta Acquisition, Underscoring Conviction Amid Market Volatility

(NYSE:BRDG) ATLANTA--(BUSINESS WIRE)-- #atlanta--Bridge Logistics Properties (“BLP”), a subsidiary of Bridge Investment Group Holdings Inc. (NYSE: BRDG) (“Bridge”), today announced the acquisition ...

Will the increased exposure to the Atlanta logistics hub improve BRDG's geographic diversification and risk profile amid current tariff volatility and macroeconomic uncertainty? What is the valuation multiple (price per square foot) for this deal compared to recent comparable Class A industrial acquisitions in the Atlanta market and to peers such as Prologis and Duke Realty? How will the $1.56M sq ft Atlanta acquisition affect Bridge Logistics Properties' (BRDG) earnings per share and cash flow outlook?
Symbol: BRDG
Mergers
14 days ago
Read more businesswire

Olezarsen significantly reduces triglycerides and acute pancreatitis events in landmark pivotal studies for people with severe hypertriglyceridemia (sHTG)

(NASDAQ:IONS) CARLSBAD, Calif.--(BUSINESS WIRE)--Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced positive topline results from the pivotal Phase 3 CORE and CORE2 studies of olezarsen in ...

What is the competitive landscape for severe hypertriglyceridemia therapies, and how does olezarsen’s efficacy and safety profile compare to existing or pipeline competitors? How will the significant reductions in triglycerides and acute pancreatitis events impact Ionis' revenue forecasts and valuation? What is the expected timeline for FDA approval and market launch of olezarsen following these Phase 3 results?
Symbol: IONS
Clinical trials
14 days ago
Read more businesswire

Pulse Biosciences Announces First Successful Procedures in PRECISE Benign Thyroid Nodule (BTN) Study

(NASDAQ:PLSE) HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) t...

How does Pulse Biosciences' nanosecond PFA technology compare to existing treatments for benign thyroid nodules and any competitive threats? What is the expected timeline for additional data releases or potential FDA clearance for the nsPFA™ system in thyroid indications? How will the successful first procedures in the PRECISE-BTN study affect Pulse Biosciences' short‑term stock performance?
Symbol: PLSE
Clinical trials
14 days ago
Read more businesswire

Equity Bancshares, Inc. Enters Nebraska, Acquires Frontier Holdings, LLC

(NYSE:EQBK) WICHITA, Kan.--(BUSINESS WIRE)-- #EquityBankUSA--Equity Bancshares, Inc. (NYSE: EQBK), (“Equity”, “the Company,” “we,” “us,” “our”), the Wichita-based holding company of Equity Bank, an...

Are there any regulatory or integration risks that could delay or affect the expected synergies from the Frontier Bank merger? What impact will the addition of seven Nebraska locations have on the company's regional market share and deposit growth? How will the acquisition affect Equity Bancshares' earnings per share forecasts and valuation multiples?
Symbol: EQBK
Mergers
14 days ago
Read more businesswire

United Therapeutics Corporation Announces TETON-2 Pivotal Study of Tyvaso® Meets Primary Endpoint for the Treatment of Idiopathic Pulmonary Fibrosis

(NASDAQ:UTHR) SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced that its TETON-2 stud...

How does Tyvaso®'s efficacy and safety profile compare to existing and pipeline IPF therapies, and what market share could it realistically capture? What is the anticipated timeline for regulatory approval and market launch of Tyvaso® for IPF, and what milestones remain? How will the positive TETON-2 results influence United Therapeutics' short‑term stock price and trading volume?
Symbol: UTHR
Clinical trials
14 days ago
Read more businesswire

Golden Arrow Reports Exciting New Gold Results from the Noemi Target at the San Pietro Project, Chile

(GRG) TSX Venture Exchange (TSX-V): GRG Frankfurt Stock Exchange (FSE): G6A OTCQB Venture Market (OTCQB): GARWF www.goldenarrowresources.com • [email protected] VANCOUVER, BC, Sept. 2, ...

How does the announced data compare with recent results from peer junior miners operating in Chile, and what could it mean for valuation multiples? What is the expected impact of the San Pietro Project’s performance on GRG’s upcoming drilling program and capital budget? How will the new gold results from the Noemi target affect Golden Arrow’s short‑term cash flow and resource estimates?
Symbol: GRG
Mining
14 days ago
Read more prnewswire